LAURENCE MCCULLOUGH to Neoplasms
This is a "connection" page, showing publications LAURENCE MCCULLOUGH has written about Neoplasms.
Connection Strength
0.288
-
Is Whole-Exome Sequencing an Ethically Disruptive Technology? Perspectives of Pediatric Oncologists and Parents of Pediatric Patients With Solid Tumors. Pediatr Blood Cancer. 2016 Mar; 63(3):511-5.
Score: 0.178
-
Pediatric Cancer Genetics Research and an Evolving Preventive Ethics Approach for Return of Results after Death of the Subject. J Law Med Ethics. 2015; 43(3):529-37.
Score: 0.042
-
Decision making in pediatric oncology: who should take the lead? The decisional priority in pediatric oncology model. J Clin Oncol. 2006 Jan 01; 24(1):160-5.
Score: 0.023
-
A clinically comprehensive ethical framework for offering and recommending cancer treatment before and during pregnancy. Cancer. 2004 Jan 15; 100(2):215-22.
Score: 0.020
-
Androgen Insensitivity Syndrome: Management Considerations from Infancy to Adulthood. Pediatr Endocrinol Rev. 2015 Jun; 12(4):373-87.
Score: 0.011
-
Point-counterpoint. Ethics and genomic incidental findings. Science. 2013 May 31; 340(6136):1047-8.
Score: 0.009
-
Improving informed consent: the medium is not the message. IRB. 2003 Sep-Oct; Suppl 25(5):S11-S19.
Score: 0.005